Rui Avelar
2021
In 2021, Rui Avelar earned a total compensation of $1.2M as Chief Medical Officer and Head of Research and Development at Evolus.
Compensation breakdown
| Non-Equity Incentive Plan | $207,390 |
|---|---|
| Salary | $445,000 |
| Stock Awards | $582,300 |
| Other | $7,687 |
| Total | $1,242,377 |
Avelar received $582.3K in stock awards, accounting for 47% of the total pay in 2021.
Avelar also received $207.4K in non-equity incentive plan, $445K in salary and $7.7K in other compensation.
Rankings
In 2021, Rui Avelar's compensation ranked 7,990th out of 12,415 executives tracked by ExecPay. In other words, Avelar earned more than 35.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,990 out of 12,415 | 36th |
Division Manufacturing | 3,531 out of 5,505 | 36th |
Major group Chemicals And Allied Products | 1,568 out of 2,375 | 34th |
Industry group Drugs | 1,393 out of 2,096 | 34th |
Industry Pharmaceutical Preparations | 1,033 out of 1,546 | 33rd |
Source: SEC filing on May 8, 2023.
Avelar's colleagues
We found two more compensation records of executives who worked with Rui Avelar at Evolus in 2021.